Skip to main content

Published locations for FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasis

User login

  • Reset your password
  • /content/fda-approves-il-23-inhibitor-risankizumab-treating-plaque-psoriasis
  • /edermatologynews/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque
  • /fedprac/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque-psoriasis
  • /rheumatologynews/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque
  • /jcomjournal/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque
  • /rheumatology/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque
  • /dermatology/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab-treating-plaque
  • /rheumatology/psoriatic-arthritis-resource-center/article/199493/psoriasis/fda-approves-il-23
  • /dermatology/psoriasiscollection/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab
  • /psoriatic-arthritis-icymi/article/199493/psoriasis/fda-approves-il-23-inhibitor-risankizumab